Register for our free email digests:
Latest From Acambis Inc.
Sanofi's divestment of its ACAM200 smallpox vaccine frees it to focus on "current and emerging" infectious disease jabs - while expanding Emergent BioSolutions adds to its anti-bioterror product offering.
- Laboratory Testing Services
- Consumables, Central Supplies
- Infection Control-Sterilization
- Surgical Equipment & Devices
- Therapeutic Areas
- Infectious & Viral Diseases
- North America
- Parent & Subsidiaries
- Steris Corp.
- Senior Management
Walter, Jr. M Rosebrough, Pres. & CEO
Michael J Tokich, SVP, CFO
- Contact Info
Phone: (440) 354-2600
5960 Heisley Rd.
Mentor, OH 44060
You must sign in to use this functionality
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.